Alkem Lab

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,702.50",
    "chg": 181,
    "chgp": "3.28%",
    "dir": 1,
    "prev_price": "5,521.50",
    "mcapval": "67,650.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE540L01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.77 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Alkem Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alkem-laboratories-ltd-fallingrising-3815148",
        "imagepath": "",
        "date": "2026-02-02 00:53:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>On 01-Feb, Alkem Laboratories Ltd’s shares fell by ₹96.65, marking a 1.7% drop by 8:43 PM. This decline is part of a broader short-term weakness, with the stock having lost 3.1% over the past four consecutive trading days. The intraday low touched ₹5,513.95, representing a 2.8% dip from recent levels. This underperformance is notable when compared to the sector, as the stock lagged by 1.23% on the day.</p>\n<p>Despite this short-term softness, the stock remains above its 200-day moving average, signalling that the longer-term trend is still intact. However, it is currently trading below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating some near-term selling pressure and potential resistance levels that investors are wa..."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-hold-3804009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_mojoScore_3804009.png",
        "date": "2026-01-25 10:10:30",
        "description": "Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3802182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3802182.png",
        "date": "2026-01-23 15:01:10",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock continues to trade near its 52-week high, supported by robust volume and rising investor participation, reflecting a cautiously optimistic outlook among traders and investors alike."
      },
      {
        "title": "Alkem Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amid-mixed-price-action-3802003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3802003.png",
        "date": "2026-01-23 14:01:01",
        "description": "Alkem Laboratories Ltd (ALKE M) has witnessed a notable 11.8% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal dip in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets in the pharmaceuticals sector, warranting close attention from traders and investors alike."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3800561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3800561.png",
        "date": "2026-01-22 15:01:21",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, with a 30.6% increase to 20,668 contracts, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s recent price action and volume patterns suggest a nuanced outlook, with mixed signals emerging from both futures and options markets."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-surge-in-derivatives-open-interest-amid-mixed-market-signals-3800423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3800423.png",
        "date": "2026-01-22 14:00:49",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap’s open interest jumped by 24.5% to 19,699 contracts, reflecting increased speculative interest and potential directional bets as the stock trades near its 52-week high."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3800347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3800347.png",
        "date": "2026-01-22 13:00:48",
        "description": "Alkem Laboratories Ltd has witnessed a significant 20.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.36% gain in the stock price, the underlying volume and open interest data suggest nuanced directional bets as the pharmaceutical mid-cap navigates a complex market environment."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Derivatives Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-derivatives-activity-3800261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_oi_spurts_by_underlying_3800261.png",
        "date": "2026-01-22 12:00:20",
        "description": "Alkem Laboratories Ltd (ALKE M) has witnessed a notable 14.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This increase accompanies a 1.29% rise in the stock price, which is trading close to its 52-week high, reflecting a complex interplay of bullish and cautious sentiment among traders and investors alike."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-hold-3791787",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlkemLaboratori_mojoScore_3791787.png",
        "date": "2026-01-14 10:10:37",
        "description": "Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 491,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding 'Intimation of Opening of Trading Window'.",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated November 01, 2019, titled \"Closure of US FDA Inspection at Alkem s manufacturing facility located at Daman, India and Baddi, India. \".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "01-Nov-2019"
    },
    {
      "details": "Alkem Laboratories Limited has informed the Exchange regarding a press release dated October 22, 2019, titled \"Update on US FDA Inspection at Alkem s Bioequivalence Center at Taloja\".",
      "source": "NSE",
      "caption": "Alkem Laboratories Limited - Press Release",
      "datetime": "22-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Alkem Laboratories Ltd falling/rising?

2026-02-02 00:53:15

Recent Price Movement and Market Context

On 01-Feb, Alkem Laboratories Ltd’s shares fell by ₹96.65, marking a 1.7% drop by 8:43 PM. This decline is part of a broader short-term weakness, with the stock having lost 3.1% over the past four consecutive trading days. The intraday low touched ₹5,513.95, representing a 2.8% dip from recent levels. This underperformance is notable when compared to the sector, as the stock lagged by 1.23% on the day.

Despite this short-term softness, the stock remains above its 200-day moving average, signalling that the longer-term trend is still intact. However, it is currently trading below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating some near-term selling pressure and potential resistance levels that investors are wa...

Read full news article

Alkem Laboratories Ltd is Rated Hold

2026-01-25 10:10:30

Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-01-23 15:01:10

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock continues to trade near its 52-week high, supported by robust volume and rising investor participation, reflecting a cautiously optimistic outlook among traders and investors alike.

Read full news article

Alkem Laboratories Sees Significant Open Interest Surge Amid Mixed Price Action

2026-01-23 14:01:01

Alkem Laboratories Ltd (ALKE M) has witnessed a notable 11.8% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal dip in the stock price, the surge in open interest alongside rising volumes suggests evolving directional bets in the pharmaceuticals sector, warranting close attention from traders and investors alike.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-01-22 15:01:21

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, with a 30.6% increase to 20,668 contracts, signalling heightened market activity and shifting investor positioning. Despite this, the stock’s recent price action and volume patterns suggest a nuanced outlook, with mixed signals emerging from both futures and options markets.

Read full news article

Alkem Laboratories Sees Sharp Surge in Derivatives Open Interest Amid Mixed Market Signals

2026-01-22 14:00:49

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical mid-cap’s open interest jumped by 24.5% to 19,699 contracts, reflecting increased speculative interest and potential directional bets as the stock trades near its 52-week high.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-01-22 13:00:48

Alkem Laboratories Ltd has witnessed a significant 20.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 1.36% gain in the stock price, the underlying volume and open interest data suggest nuanced directional bets as the pharmaceutical mid-cap navigates a complex market environment.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Derivatives Activity

2026-01-22 12:00:20

Alkem Laboratories Ltd (ALKE M) has witnessed a notable 14.4% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. This increase accompanies a 1.29% rise in the stock price, which is trading close to its 52-week high, reflecting a complex interplay of bullish and cautious sentiment among traders and investors alike.

Read full news article

Alkem Laboratories Ltd is Rated Hold

2026-01-14 10:10:37

Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News